Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Metastatic Castration-resistant Prostate Cancer × 177Lu-EB-PSMA-617 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Metastatic Castration-resistant Prostate Cancer 1 Carcinoma, Renal Cell 1 Carcinoma, Adenoid Cystic 1

Interventions

Docetaxel 2 pamiparib 1 fludarabine 1 cabazitaxel 1 Single Photon Emission Computed Tomography Computed Tomography 1 Selegiline 1 Cyclophosphamide 1 177Lu-EB-PSMA-617 1 (225)Ac-PSMA-617 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03403595 2018-01-18

177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate Cancer

Peking Union Medical College Hospital

Phase 1 Unknown

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡